Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
Study NCT ID:
NCT01559935
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-08
First Post:
2012-02-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma
Sponsor:
Weill Medical College of Cornell University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2012-02-16
First Submit QC Date:
None
Study First Post Date:
2012-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-01
Results First Submit QC Date:
None
Results First Post Date:
2017-03-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-26
Last Update Post Date:
2025-09-08
Last Update Post Date Type:
ESTIMATED